Optimizing the Intraoperative Management of Neuromuscular Blockade in High-Risk Patients


This program supports Canadian pharmacists in optimizing their knowledge of the intraoperative management of neuromuscular blockade and the medications used to reverse neuromuscular blockade (neuromuscular reversal agents). This program focuses on high-risk patient populations and the efficacy and safety considerations when managing neuromuscular blockade in these patients. The efficacy and limitations of neuromuscular reversal agents will be illustrated through case-based learning, to increase comfort and confidence in knowledgably using these medications.

This program has received an educational grant or in-kind support from Merck.